{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:24:28Z","timestamp":1790940268436,"version":"4.1.0"},"reference-count":37,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.3892\/or.2012.1915","type":"journal-article","created":{"date-parts":[[2012,7,16]],"date-time":"2012-07-16T06:21:24Z","timestamp":1342419684000},"page":"1332-1338","source":"Crossref","is-referenced-by-count":19,"title":["AAV2-mediated gene transfer of VEGF-Trap with potent suppression of primary breast tumor growth and spontaneous pulmonary metastases by long-term expression"],"prefix":"10.3892","volume":"28","author":[{"given":"LIAN","family":"LU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHUN-TAO","family":"LUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUA SHAN","family":"SHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MENG","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAI LONG","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHA SHA","family":"HE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YAN","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YING","family":"PAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LI","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,7,16]]},"reference":[{"key":"key20180107215523_b1-or-28-04-1332","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1470-2045(01)00586-1","article-title":"Angiogenesis as a biomarker and target in cancer chemoprevention","volume":"2","author":"Sharma","year":"2001","journal-title":"Lancet Oncol"},{"key":"key20180107215523_b2-or-28-04-1332","first-page":"2061","article-title":"Angiogenesis in pre-invasive cancers","volume":"22","author":"Teo","year":"2002","journal-title":"Anticancer Res"},{"key":"key20180107215523_b3-or-28-04-1332","doi-asserted-by":"crossref","first-page":"835viii","DOI":"10.1016\/S0889-8588(05)70254-9","article-title":"Antiangiogenesis therapy. Current and future agents","volume":"15","author":"Kieran","year":"2001","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20180107215523_b4-or-28-04-1332","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"key20180107215523_b5-or-28-04-1332","first-page":"930","article-title":"Angiogenesis and antiangiogenic cancer therapy","volume":"50","author":"Pour","year":"2004","journal-title":"Vnitr Lek"},{"key":"key20180107215523_b6-or-28-04-1332","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O\u2019Reilly","year":"1994","journal-title":"Cell"},{"key":"key20180107215523_b7-or-28-04-1332","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O\u2019Reilly","year":"1997","journal-title":"Cell"},{"key":"key20180107215523_b8-or-28-04-1332","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jcb.240470308","article-title":"A metalloproteinase inhibitor as an inhibitor of neovascularization","volume":"47","author":"Moses","year":"1991","journal-title":"J Cell Biochem"},{"key":"key20180107215523_b9-or-28-04-1332","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0092-8674(89)90238-9","article-title":"Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene","volume":"56","author":"Rastinejad","year":"1989","journal-title":"Cell"},{"key":"key20180107215523_b10-or-28-04-1332","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","article-title":"Vascular-specific growth factors and blood vessel formation","volume":"407","author":"Yancopoulos","year":"2000","journal-title":"Nature"},{"key":"key20180107215523_b11-or-28-04-1332","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm0603-685","article-title":"Molecular regulation of vessel maturation","volume":"9","author":"Jain","year":"2003","journal-title":"Nat Med"},{"key":"key20180107215523_b12-or-28-04-1332","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"key":"key20180107215523_b13-or-28-04-1332","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","article-title":"Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo","volume":"362","author":"Kim","year":"1993","journal-title":"Nature"},{"key":"key20180107215523_b14-or-28-04-1332","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr Rev"},{"key":"key20180107215523_b15-or-28-04-1332","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/367576a0","article-title":"Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant","volume":"367","author":"Millauer","year":"1994","journal-title":"Nature"},{"key":"key20180107215523_b16-or-28-04-1332","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1073\/pnas.172398299","article-title":"VEGF-Trap: a VEGF blocker with potent antitumor effects","volume":"99","author":"Holash","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107215523_b17-or-28-04-1332","doi-asserted-by":"crossref","first-page":"11399","DOI":"10.1073\/pnas.172398399","article-title":"Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma","volume":"99","author":"Kim","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107215523_b18-or-28-04-1332","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1215\/15228517-2008-061","article-title":"VEGF Trap induces antiglioma effect at different stages of disease","volume":"10","author":"Gomez-Manzano","year":"2008","journal-title":"Neuro Oncol"},{"key":"key20180107215523_b19-or-28-04-1332","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/gt.2008.54","article-title":"Immunity to adeno-associated virus vectors in animals and humans: a continued challenge","volume":"15","author":"Zaiss","year":"2008","journal-title":"Gene Ther"},{"key":"key20180107215523_b20-or-28-04-1332","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/4743","article-title":"Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector","volume":"5","author":"Herzog","year":"1999","journal-title":"Nat Med"},{"key":"key20180107215523_b21-or-28-04-1332","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1073\/pnas.96.7.3906","article-title":"Sustained correction of bleeding disorder in hemophilia B mice by gene therapy","volume":"96","author":"Wang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107215523_b22-or-28-04-1332","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/0008-5472.CAN-03-1786","article-title":"Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor","volume":"64","author":"Ponnazhagan","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107215523_b23-or-28-04-1332","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-0556-8-8","article-title":"AAV2-mediated in vivo immune gene therapy of solid tumours","volume":"8","author":"Collins","year":"2010","journal-title":"Genet Vaccines Ther"},{"key":"key20180107215523_b24-or-28-04-1332","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas","year":"2005","journal-title":"Cancer Cell"},{"key":"key20180107215523_b25-or-28-04-1332","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A","article-title":"Vascular endothelial growth factor expression in early stage ovarian carcinoma","volume":"80","author":"Paley","year":"1997","journal-title":"Cancer"},{"key":"key20180107215523_b26-or-28-04-1332","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1200\/JCO.2007.13.5947","article-title":"VEGF polymorphisms and survival in early-stage non-small cell lung cancer","volume":"26","author":"Heist","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107215523_b27-or-28-04-1332","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1128\/MCB.10.9.4728","article-title":"Diverse forms of a receptor for acidic and basic fibroblast growth factors","volume":"10","author":"Johnson","year":"1990","journal-title":"Mol Cell Biol"},{"key":"key20180107215523_b28-or-28-04-1332","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-230X(08)60305-X","article-title":"The FGF family of growth factors and oncogenes","volume":"59","author":"Basilico","year":"1992","journal-title":"Adv Cancer Res"},{"key":"key20180107215523_b29-or-28-04-1332","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","volume":"2","author":"Ferrara","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107215523_b30-or-28-04-1332","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/70928","article-title":"Clinical applications of angiogenic growth factors and their inhibitors","volume":"5","author":"Ferrara","year":"1999","journal-title":"Nat Med"},{"key":"key20180107215523_b31-or-28-04-1332","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat Med"},{"issue":"Suppl 4","key":"key20180107215523_b32-or-28-04-1332","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/annonc\/10.suppl_4.S60","article-title":"Angiogenesis and anti-angiogenesis: perspectives for the treatment of solid tumors","volume":"10","author":"Van Hinsbergh","year":"1999","journal-title":"Ann Oncol"},{"key":"key20180107215523_b33-or-28-04-1332","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1073\/pnas.081615298","article-title":"Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer","volume":"98","author":"Kuo","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107215523_b34-or-28-04-1332","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nm0398-336","article-title":"Vascular endothelial growth factor is essential for corpus luteum angiogenesis","volume":"4","author":"Ferrara","year":"1998","journal-title":"Nat Med"},{"key":"key20180107215523_b35-or-28-04-1332","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/9467","article-title":"VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation","volume":"5","author":"Gerber","year":"1999","journal-title":"Nat Med"},{"key":"key20180107215523_b36-or-28-04-1332","first-page":"6253","article-title":"Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor","volume":"60","author":"Gerber","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107215523_b37-or-28-04-1332","doi-asserted-by":"crossref","first-page":"9064","DOI":"10.1073\/pnas.95.16.9064","article-title":"Antiangiogenic gene therapy","volume":"95","author":"Folkman","year":"1998","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.1915\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:55:35Z","timestamp":1515344135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.1915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,16]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,7,16]]},"published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.3892\/or.2012.1915"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.1915","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,16]]}}}